These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36067040)

  • 1. Functional assessment of homozygous ALDH18A1 variants reveals alterations in amino acid and antioxidant metabolism.
    Colonna MB; Moss T; Mokashi S; Srikanth S; Jones JR; Foley JR; Skinner C; Lichty A; Kocur A; Wood T; Stewart TM; Casero RA; Flanagan-Steet H; Edison AS; Lyons MJ; Steet R
    Hum Mol Genet; 2023 Feb; 32(5):732-744. PubMed ID: 36067040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent De Novo Mutations Affecting Residue Arg138 of Pyrroline-5-Carboxylate Synthase Cause a Progeroid Form of Autosomal-Dominant Cutis Laxa.
    Fischer-Zirnsak B; Escande-Beillard N; Ganesh J; Tan YX; Al Bughaili M; Lin AE; Sahai I; Bahena P; Reichert SL; Loh A; Wright GD; Liu J; Rahikkala E; Pivnick EK; Choudhri AF; Krüger U; Zemojtel T; van Ravenswaaij-Arts C; Mostafavi R; Stolte-Dijkstra I; Symoens S; Pajunen L; Al-Gazali L; Meierhofer D; Robinson PN; Mundlos S; Villarroel CE; Byers P; Masri A; Robertson SP; Schwarze U; Callewaert B; Reversade B; Kornak U
    Am J Hum Genet; 2015 Sep; 97(3):483-92. PubMed ID: 26320891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal recessive cutis laxa type IIIA: Report of a patient with severe phenotype and review of the literature.
    Lugli L; Cavalleri F; Bertucci E; Fischer-Zirnsak B; Cinelli G; Trevisani V; Rossi C; Riva M; Iughetti L; Berardi A
    Eur J Med Genet; 2022 Sep; 65(9):104568. PubMed ID: 35842092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Δ
    Marco-Marín C; Escamilla-Honrubia JM; Llácer JL; Seri M; Panza E; Rubio V
    J Inherit Metab Dis; 2020 Jul; 43(4):657-670. PubMed ID: 32017139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia.
    Coutelier M; Goizet C; Durr A; Habarou F; Morais S; Dionne-Laporte A; Tao F; Konop J; Stoll M; Charles P; Jacoupy M; Matusiak R; Alonso I; Tallaksen C; Mairey M; Kennerson M; Gaussen M; Schule R; Janin M; Morice-Picard F; Durand CM; Depienne C; Calvas P; Coutinho P; Saudubray JM; Rouleau G; Brice A; Nicholson G; Darios F; Loureiro JL; Zuchner S; Ottolenghi C; Mochel F; Stevanin G
    Brain; 2015 Aug; 138(Pt 8):2191-205. PubMed ID: 26026163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALDH18A1-related cutis laxa syndrome with cyclic vomiting.
    Nozaki F; Kusunoki T; Okamoto N; Yamamoto Y; Miya F; Tsunoda T; Kosaki K; Kumada T; Shibata M; Fujii T
    Brain Dev; 2016 Aug; 38(7):678-84. PubMed ID: 26829900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe congenital cutis laxa with cardiovascular manifestations due to homozygous deletions in ALDH18A1.
    Fischer B; Callewaert B; Schröter P; Coucke PJ; Schlack C; Ott CE; Morroni M; Homann W; Mundlos S; Morava E; Ficcadenti A; Kornak U
    Mol Genet Metab; 2014 Aug; 112(4):310-6. PubMed ID: 24913064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound heterozygous mutations in two different domains of ALDH18A1 do not affect the amino acid levels in a patient with hereditary spastic paraplegia.
    Steenhof M; Kibæk M; Larsen MJ; Christensen M; Lund AM; Brusgaard K; Hertz JM
    Neurogenetics; 2018 Aug; 19(3):145-149. PubMed ID: 29754261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tremor as an early sign of hereditary spastic paraplegia due to mutations in ALDH18A1.
    Kalmár T; Maróti Z; Zimmermann A; Sztriha L
    Brain Dev; 2021 Jan; 43(1):144-151. PubMed ID: 32798076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutis laxa, fat pads and retinopathy due to ALDH18A1 mutation and review of the literature.
    Wolthuis DF; van Asbeck E; Mohamed M; Gardeitchik T; Lim-Melia ER; Wevers RA; Morava E
    Eur J Paediatr Neurol; 2014 Jul; 18(4):511-5. PubMed ID: 24767728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPG9A with the new occurrence of an ALDH18A1 mutation in a CMT1A family with PMP22 duplication: case report.
    Koh K; Takaki R; Ishiura H; Tsuji S; Takiyama Y
    BMC Neurol; 2021 Feb; 21(1):64. PubMed ID: 33573605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further expansion of the phenotypic spectrum associated with mutations in ALDH18A1, encoding Δ¹-pyrroline-5-carboxylate synthase (P5CS).
    Skidmore DL; Chitayat D; Morgan T; Hinek A; Fischer B; Dimopoulou A; Somers G; Halliday W; Blaser S; Diambomba Y; Lemire EG; Kornak U; Robertson SP
    Am J Med Genet A; 2011 Aug; 155A(8):1848-56. PubMed ID: 21739576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A missense mutation in ALDH18A1, encoding Delta1-pyrroline-5-carboxylate synthase (P5CS), causes an autosomal recessive neurocutaneous syndrome.
    Bicknell LS; Pitt J; Aftimos S; Ramadas R; Maw MA; Robertson SP
    Eur J Hum Genet; 2008 Oct; 16(10):1176-86. PubMed ID: 18478038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase.
    Baumgartner MR; Hu CA; Almashanu S; Steel G; Obie C; Aral B; Rabier D; Kamoun P; Saudubray JM; Valle D
    Hum Mol Genet; 2000 Nov; 9(19):2853-8. PubMed ID: 11092761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine.
    Martinelli D; Häberle J; Rubio V; Giunta C; Hausser I; Carrozzo R; Gougeard N; Marco-Marín C; Goffredo BM; Meschini MC; Bevivino E; Boenzi S; Colafati GS; Brancati F; Baumgartner MR; Dionisi-Vici C
    J Inherit Metab Dis; 2012 Sep; 35(5):761-76. PubMed ID: 22170564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel homozygous variants of ATP6V0A2 and ALDH18A1 lead to autosomal recessive cutis laxa type 2 and 3 in two Pakistani families.
    Zaman Q; Iftikhar A; Rehman G; Khan Q; Najumuddin ; Jan A; Khan J; Anas M; Laiba ; Umair M; Muthaffar OY; Abdulkareem AA; Bibi F; Naseer MI; Jelani M
    J Gene Med; 2023 Oct; 25(10):e3522. PubMed ID: 37119015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Compound Missense and Intronic Splicing Mutation in
    Chen YJ; Zhang ZQ; Wang MW; Qiu YS; Yuan RY; Dong EL; Zhao Z; Zhou HT; Wang N; Chen WJ; Lin X
    Front Neurol; 2021; 12():627531. PubMed ID: 34093392
    [No Abstract]   [Full Text] [Related]  

  • 18. Autosomal dominant cutis laxa with progeroid features due to a novel, de novo mutation in ALDH18A1.
    Bhola PT; Hartley T; Bareke E; ; Boycott KM; Nikkel SM; Dyment DA
    J Hum Genet; 2017 Jun; 62(6):661-663. PubMed ID: 28228640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation in pyrroline-5-carboxylate reductase 1 gene in families with cutis laxa type 2.
    Guernsey DL; Jiang H; Evans SC; Ferguson M; Matsuoka M; Nightingale M; Rideout AL; Provost S; Bedard K; Orr A; Dubé MP; Ludman M; Samuels ME
    Am J Hum Genet; 2009 Jul; 85(1):120-9. PubMed ID: 19576563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Delta1-pyrroline-5-carboxylate synthase: function and regulation.
    Hu CA; Khalil S; Zhaorigetu S; Liu Z; Tyler M; Wan G; Valle D
    Amino Acids; 2008 Nov; 35(4):665-72. PubMed ID: 18401542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.